• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Akila N. Viswanathan, MD, MPH


  • Viswanathan AN, Szymonifka J, Tempany-Afdhal CM, O'Farrell DA, Cormack RA.A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy.Brachytherapy.;12(3):240-7.
  • Townamchai K, Berkowitz R, Bhagwat M, Damato AL, Friesen S, Lee LJ, Matulonis U, O'Farrell D, Viswanathan AN.Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.Gynecol Oncol. 2013 Apr;129(1):18-21.
  • Poorvu PD, Sadow CA, Townamchai K, Damato AL, Viswanathan AN.Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1262-8.
  • Lee LJ, Damato AL, Viswanathan AN.Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance.Brachytherapy. 2013 Mar 12.
  • Lee LJ, Viswanathan AN.Predictors of toxicity after image-guided high-dose-rate interstitial brachytherapy for gynecologic cancer.Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1192-7.
  • Townamchai K, Lee L, Viswanathan AN.A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer.Gynecol Oncol. 2012 Nov;127(2):351-5.
  • Kapur T, Egger J, Damato A, Schmidt EJ, Viswanathan AN.3-T MR-guided brachytherapy for gynecologic malignancies.Magn Reson Imaging. 2012 Nov;30(9):1279-90.
  • Lee LJ, Viswanathan AN.Combined chemotherapy and radiation improves survival for node-positive endometrial cancer.Gynecol Oncol. 2012 Oct;127(1):32-7.
  • Viswanathan AN, Creutzberg CL, Craighead P, McCormack M, Toita T, Narayan K, Reed N, Long H, Kim HJ, Marth C, Lindegaard JC, Cerrotta A, Small W, Trimble E.International Brachytherapy Practice Patterns: A Survey of the Gynecologic Cancer Intergroup (GCIG).Int J Radiat Oncol Biol Phys. 2010 Dec 22.
  • Holloway CL, Macklin EA, Cormack RA, Viswanathan AN.Should the organs at risk be contoured in vaginal cuff brachytherapy?.Brachytherapy. 2010 Dec 28.
  • Mak RH, Halasz LM, Tanaka CK, Ancukiewicz M, Schultz DJ, Russell AH, Viswanathan AN.Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva.Gynecol Oncol. 2011 Jan;120(1):101-7.
  • Viswanathan AN.Childhood cancer survivors: stillbirth and neonatal death.Lancet. 2010 Aug 21;376(9741):570-2.
  • Viswanathan AN, Yorke ED, Marks LB, Eifel PJ, Shipley WU.Radiation dose-volume effects of the urinary bladder.Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S116-22. Review.
  • Chang MC, Nevadunsky NS, Viswanathan AN, Crum CP, Feltmate CM.Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival.Int J Gynecol Pathol. 2010 Jan;29(1):88-92.
  • Viswanathan AN, Erickson BA.Three-Dimensional Imaging in Gynecologic Brachytherapy: A Survey of the American Brachytherapy Society.Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):104-9.
  • Viswanathan AN, Cormack R, Rawal B, Lee H.Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer.Int J Gynecol Cancer. 2009 Nov;19(8):1402-6.
  • Holloway CL, Racine ML, Cormack RA, O'Farrell DA, Viswanathan AN.Sigmoid dose using 3D imaging in cervical-cancer brachytherapy.Radiother Oncol. 2009 Nov;93(2):307-10.
  • Lee LJ,Sadow CA,Russell A,Viswanathan AN.Correlation of Point B and Lymph Node Dose in 3D-Planned High-Dose-Rate Cervical Cancer Brachytherapy.Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):803-9.
  • Racine ML, Holloway CL, Cormack RA, O'Farrell DA, Viswanathan AN.Dosimetric Analysis of 3D Image-Guided Cervical Cancer Low-dose-rate Tandem and Ovoid and Interstitial Brachytherapy.Brachytherapy..
  • Viswanathan AN,Schernhammer ES.Circulating melatonin and the risk of breast and endometrial cancer in women.Cancer Lett. 2009 Aug 18;281(1):1-7. Review.
  • Wo JY,Viswanathan AN.Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients.Int J Radiat Oncol Biol Phys. 2009 Apr 1;73(5):1304-12. Review.
  • Lin MC,Burkholder KA,Viswanathan AN,Neuberg D,Mutter GL.Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms.Cancer. 2009 May 15;115(10):2111-8.
  • Stewart AJ, Cormack RA, Lee H, Xiong L, Hansen JL, O'Farrell DA, Viswanathan AN.Prospective Clinical Trial of Bladder Filling and Three-Dimensional Dosimetry in High-Dose-Rate Vaginal Cuff Brachytherapy.Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):843-8.
  • Viswanathan AN, Buttin BM, Kennedy AM.Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer.Radiographics. 2008 Jan-Feb;28(1):289-307.
  • Viswanathan AN, Feskanich D, Schernhammer ES, Hankinson SE.Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer.Cancer Res. 2008 Apr 1;68(7):2507-13.
  • Haglund KE, Viswanathan AN.Computed Tomography-Based Radiation Therapy of Ovarian Remnants for Symptomatic Persistent Endometriosis.Obstet Gynecol. 2008 Feb;111(2):579-583.
  • Viswanathan AN.The Frank Ellis Memorial Lecture: the Use of Three-dimensional Imaging in Gynaecological Radiation Therapy.Clin Oncol (R Coll Radiol). 2008 Feb;20(1):1-5.
  • Viswanathan AN, Hankinson SE, Schernhammer ES.Night shift work and the risk of endometrial cancer.Cancer Res. 2007 Nov 1;67(21):10618-22.
  • Viswanathan AN, Dimopoulos J, Kirisits C, Berger D, Pötter R.Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: Results of a prospective trial and preliminary guidelines for standardized contours.Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):491-8.
  • Holloway CL, Russell AH, Muto M, Albert M, Viswanathan AN.Synovial cell sarcoma of the vulva: multimodality treatment incorporating preoperative external-beam radiation, hemivulvectomy, flap reconstruction, interstitial brachytherapy, and chemotherapy.Gynecol Oncol. 2007 Jan;104(1):253-6.
  • Stewart AJ, Viswanathan AN.Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer.Cancer. 2006 Sep 1;107(5):908-15. Review.
  • Viswanathan AN, Cormack R, Holloway CL, Tanaka C, O'farrell D, Devlin PM, Tempany C.Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer.Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):91-9.
  • Xiong L, Viswanathan A, Stewart AJ, Haker S, Tempany CM, Chin LM, Cormack RA.Deformable structure registration of bladder through surface mapping.Med Phys. 2006 Jun;33(6):1848-56.
  • Viswanathan AN, Lee H, Hanson E, Berkowitz RS, Crum CP.Influence of margin status and radiation on recurrence after radical hysterectomy in stage IB cervical cancer.Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1501-7.
  • Viswanathan AN, Feskanich D, De Vivo I, Hunter DJ, Barbieri RL, Rosner B, Colditz GA, Hankinson SE.Smoking and the risk of endometrial cancer: results from the Nurses' Health Study.Int J Cancer. 2005 May 10;114(6):996-1001.
  • Viswanathan AN, Deavers MT, Jhingran A, Ramirez PT, Levenback C, Eifel PJ.Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.Gynecol Oncol. 2004 Apr;93(1):27-33.
  • Viswanathan AN, Grier HE, Litman HJ, Perez-Atayde A, Tarbell NJ, Neuberg D, Shamberger RC, Marcus KJ.Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1208-14.
  • Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH.Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.J Clin Oncol. 2001 Aug 15;19(16):3685-91.
  • Arbiser JL, Karalis K, Viswanathan A, Koike C, Anand-Apte B, Flynn E, Zetter B, Majzoub JA.Corticotropin-releasing hormone stimulates angiogenesis and epithelial tumor growth in the skin.J Invest Dermatol. 1999 Nov;113(5):838-42.
  • Anand-Apte B, Zetter BR, Viswanathan A, Qiu RG, Chen J, Ruggieri R, Symons M.Platelet-derived growth factor and fibronectin-stimulated migration are differentially regulated by the Rac and extracellular signal-regulated kinase pathways.J Biol Chem. 1997 Dec 5;272(49):30688-92.